Investments, Funding & Disinvestment

The ministry and Samsung is exploring plans to establish a state-of-the-art training facility equipped with advanced technologies that can support the practical training of healthcare professionals.

Evonik will use the funding to upgrade major production assets, including large reactors and other critical processing systems.

The Nottingham site also supports Codis’ commercial spray-drying operations in Haverhill, U.K., where the company is increasing capacity by installing a new GEA Pharma-SD PSD-4 commercial spray dryer, with validation planned for 2027.

Under the agreement, Everest Medicines will receive US$112.5 million upfront from Travere Therapeutics and could earn up to US$1.03 billion more in milestone payments if certain clinical, regulatory, and commercial goals are met across five indications.

The new collaboration centres on CSPC’s small interfering RNA (siRNA) drug discovery platform and its proprietary delivery technology, which is designed to transport therapies beyond the liver.

Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.

The financing round was co-led by M Ventures, the venture capital arm of Merck KGaA, and GordonMD Global Investments.

Following completion of the transaction, the business will operate under the new name Medswana Laborex and become part of CFAO Healthcare’s pan-African network.

The new Strengthening Public Health Surveillance and Resilient Knowledge for Non-Communicable Diseases in Africa (SPARK-NCD) programme aims to improve disease surveillance, workforce capacity, and integrated care across the continent.

Astex will also qualify for development, regulatory, and commercial milestone payments exceeding US$465 million, totaling US$490 million with the upfront payment included.